Anti-MOG Antibody, clone 2I9 ZooMAb^® Rabbit Monoclonal

Clone 2I9 is a ZooMAb^® rabbit recombinant monoclonal antibody that detects MOG. It targets an epitope within 25 amino acids from the N-terminal extracellular domain.

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Quality Control Testing

Evaluated by Western Blotting in mouse brain tissue lysate.

Western Blotting Analysis: A 1:10,000 dilution of this antibody detected MOG in mouse brain tissue lysate.

Tested Applications

Western Blotting Analysis: A 1:10,000 dilution from a representative lot detected MOG in human and rat brain tissue lysates.

Immunohistochemistry (Paraffin) Analysis: A 1:1,000 dilution from a representative lot detected MOG in human cerebral cortex tissue sections.

Affinity Binding Assay: A representative lot of this antibody bound with MOG peptide with at least one billion-fold (1,000,000,000X) higher affinity than with non-specific control peptide.

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.

ZooMAb^® antibodies represent an entirely new generation of recombinant monoclonal antibodies. Each ZooMAb^® antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb^® antibodies are reliably available and ready to ship when you need them.

Myelin-oligodendrocyte glycoprotein (UniProt: Q16653) is encoded by the MOG gene (Gene ID: 4340) in human. Myelin oligodendrocyte glycoprotein (MOG) is a type I integral membrane protein predominantly expressed in the central nervous system (CNS), specifically on the outermost surface of myelin sheaths and oligodendrocyte membranes. MOG is a member of the immunoglobulin superfamily, containing an extracellular Ig variable domain that adopts a beta-sandwich conformation. MOG plays a critical role in myelin sheath formation, maintenance, and integrity, as well as in cell-cell communication within the CNS. It is thought to act as an adhesion molecule, contributing to the structural stability of myelin. MOG also serves as a target for immune responses, particularly in inflammatory demyelinating diseases such as multiple sclerosis (MS) and MOG antibody-associated disease (MOGAD). Pathogenic mechanisms involve complement-dependent cytotoxicity and antibody-mediated damage, leading to demyelination and inflammation. MOG′s expression is developmentally regulated, appearing late during oligodendrocyte maturation. It is highly localized to the surface of myelin and oligodendrocyte processes, enabling its role in immune-mediated diseases. This ZooMAb^® recombinant monoclonal antibody, generated by our proprietary technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals.

KLH-conjugated linear peptide corresponding to 25 amino acids from the N-terminal extracellular domain of human MOG.

Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS with 5% Trehalose, normal appearance a coarse or translucent resin. The PBS/trehalose components in the ZooMAb formulation can have the appearance of a semi-solid (bead like gel) after lyophilization. This is a normal phenomenon. Please follow the recommended reconstitution procedure in the data sheet to dissolve the semi-solid, bead-like, gel-appearing material. The resulting antibody solution is completely stable and functional as proven by full functional testing. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 µL.

300 µg/mL after reconstitution at 25 µL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 µL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.

ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany